Ostraceous psoriasis and psoriatic arthritis: treatment with infl iximab
Keywords:
Psoriasis, arthritis, tratamientoAbstract
Psoriasis is a chronic disease of that is characterized by hiperkeratotic plaques that are caused by cellular proliferation and inflammation. Ostraceous psoriasis refers to hiperkeratotic plaques with relatively concave centers. Psoriatic arthritis belongs to the group of seronegative spondyloarthropathies that can be or not associated with skin lesions, and with axial or peripheral involvement. A man with severe skin lesions and arthritis, after eight months of labor incapacity and failure of numerous treatments, was treated with infliximab with resolution of skin lesions and progressive recovery of articulations.
Author Biographies
Christian Burbano
Residente Dermatología Universidad El Bosque, Bogotá, Colombia
Adriana Motta
Dermatóloga, Hospital Simón Bolívar, Universidad El Bosque, Bogotá, Colombia
Mario Díaz
Reumatólogo, Hospital Simón Bolívar, Bogotá, Colombia
Mariam Rolón
Dermatopatóloga, Instituto Nacional de Cancerología, Universidad El Bosque, Bogotá, Colombia
References
2. Myers W, Gottlieb A, Mease P. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms; Clinics in Dermatology; 2006, 24: 438-47.
3. Gladman D, Antoni C, Mease P, Clegg D, Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome, Ann Rheum Dis; 2005; 64 (Supll II): 14-17ii.
4. Feletar M, Brockbank J, Schentag C, Lapp V, Gladman D. Treatment of refractory psoriatic arthritis with infl iximab: a 12 month observational study of patients,Ann Rheum Dis 2004; 63: 156-61.
5. Braun J, Brandt J, Listing J, Rudwaleit M, Sieper J. Biologic therapies in the spondyloarthritis: new opportunities, new challenges, Curr Opin Rheumatol; 2003;15: 394-407.
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
